Weekly Recap | ATYR Pharma -29.33%, a one-way slide to fresh lowsWeekly Review·Oct 17, 2026 at 06:41 AMATYR-5.33%
Weekly Recap | BDRX.US -0.89%, Phase 3 milestone drives heavy churnWeekly Review·Oct 17, 2026 at 06:40 AMBDRX+5.73%
Weekly Recap | Amgen +4.25%, defensive bid amid tech pullbackWeekly Review·Oct 17, 2026 at 06:31 AMAMGN-0.35%
Weekly Recap | SPDR S&P Biotech -6.15%, near the lower end of its rangeWeekly Review·Oct 17, 2026 at 05:20 AMXBI-3.65%
Weekly Recap | LABU.US -18.19%, one-way slide into the closeWeekly Review·Oct 17, 2026 at 04:41 AMLABU-10.80%
Weekly Recap | LABD.US +19.15%, mirroring a biotech sell-offWeekly Review·Oct 17, 2026 at 04:40 AMLABD+11.30%
Weekly Recap | IBB.US -2.18%, big pharma draws inflowsWeekly Review·Oct 17, 2026 at 04:33 AMIBB-2.61%
